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Open access under CC BCharacterization of the extracellular protein interactome has lagged far behind that of intracellular pro-
teins, where mass spectrometry and yeast two-hybrid technologies have excelled. Improved methods for
identifying receptor–ligand and extracellular matrix protein interactions will greatly accelerate biological
discovery in cell signaling and cellular communication. These technologies must be able to identify low-
afﬁnity binding events that are often observed between membrane-bound coreceptor molecules during
cell–cell or cell–extracellular matrix contact. Here we demonstrate that functional protein microarrays
are particularly well-suited for high-throughput screening of extracellular protein interactions. To eval-
uate the performance of the platform, we screened a set of 89 immunoglobulin (Ig)-type receptors
against a highly diverse extracellular protein microarray with 686 genes represented. To enhance detec-
tion of low-afﬁnity interactions, we developed a rapid method to assemble bait Fc fusion proteins into
multivalent complexes using protein A microbeads. Based on these screens, we developed a statistical
methodology for hit calling and identiﬁcation of nonspeciﬁc interactions on protein microarrays. We
found that the Ig receptor interactions identiﬁed using our methodology are highly speciﬁc and display
minimal off-target binding, resulting in a 70% true-positive to false-positive hit ratio. We anticipate that
these methods will be useful for a wide variety of functional protein microarray users.
 2011 Elsevier Inc.Open access under CC BY-NC-ND license.Many orphan receptors and ligands remain within the human
secretome. Moreover, new interacting partners continue to be
identiﬁed for receptors with previously characterized ligands
[1,2], suggesting that some non-orphan receptors or ligands may
harbor yet unidentiﬁed binding partners. Deﬁning these extracel-
lular protein interaction networks will shed new light and suggest
new mechanisms for cellular communication and regulation.
Unfortunately, for a number of reasons, methods for identifying se-
creted protein interactions have remained limited [3,4].
Previously, we used a secreted protein library, the secreted pro-
tein discovery initiative (SPDI)2 [5], to identify coreceptors for the
immunoglobulin (Ig) domain-containing receptors BTLA and TIGIT
[6,7] using surface plasmon resonance (SPR) and biolayer interferom-
etry technologies. Although amenable to identifying novel extracellu-z).
y initiative; Ig, immunoglob-
hamster ovary; SDS–PAGE,
esis; PBS, phosphate-buffered
Y-NC-ND license.lar protein interactions, these systems offered limited throughput
and consumed microgram amounts of protein. To further increase
throughput and sensitivity while decreasing protein consumption,
we turned to the protein microarray platform. Protein microarrays,
initially demonstrated by MacBeath and Schreiber [8] and Zhu and
coworkers [9], offer a unique method of depositing very small
amounts of protein in a high-density format (>5000 features/slide).
A ﬂuorescently labeled, or tagged, analyte protein (the bait) is then
used to probe interactions with all of the arrayed proteins simulta-
neously. Microarrays composed of speciﬁc protein domain families
have previously been used to identify intracellular protein interac-
tions [10,11]. In vitro transcription/translation capture systems have
been developed for direct synthesis of proteins in situ on microarrays
[12,13]. Protein microarrays composed of large protein libraries from
plant, yeast, and human have also been described [9,14,15]. However,
little work has focused on investigating the robustness and broad
utility of this approach for identifying interactions among extracellu-
lar proteins.
The human Ig receptor family, deﬁned as proteins containing
exclusively one or more Ig domains, is composed of more than 200
genes with diverse functions and binding partners. Approximately
Table 1
List of 89 Ig receptors screened against the secreted protein microarray.
Number Name Number Name
1 ASAM 46 KIR3DL3
2 BSG 47 LAIR1
3 BTLA 48 LILRB2
4 BTN2A1 49 LNIR
5 BTN3A1 50 LSAMP
6 BTN3A2 51 LSR
7 BTN3A3 52 LY6G6D
8 BTNL2 53 MFAP3
9 BTNL8 54 MFAP3L
10 CADM3 55 MOG
11 CD160 56 MPZ
12 CD2 57 MPZL1
13 CD200 58 MPZL3
14 CD200R1 59 MXRA8
15 CD226 60 NCR3
16 CD244 61 NEGR1
17 CD274 62 NPTN
18 CD276 63 NTM
19 CD300C 64 PDCD1
20 CD300LD 65 PSG11
21 CD300LF 66 PSG4
22 CD33 67 PSG5
23 CD4 68 PSG7
24 CD80 69 PVRL1
25 CD84 70 PVRL2
26 CEACAM1 71 PVRL3
27 CEACAM20 72 PVRL4
28 CEACAM4 73 SCN1B
29 CEACAM6 74 SEMA4A PSI
30 CTLA4 75 SIGLEC5
31 CXADR 76 SIGLEC8
32 ERMAP 77 SIGLEC9
33 ESAM 78 SIRPA
34 F11R 79 SIRPB2
35 FCRL1 80 SLAMF1
36 FCRL2 81 SLAMF7
37 FCRL4 82 SLAMF8
38 GPA33 83 TAPBPL
39 HEPACAM2 84 TIGIT
40 HIDE1 85 TMIGD1
41 ICAM 86 TREM1
42 ICOS 87 TREM2
43 IGSF11 88 TREML4
44 JAM2 89 VSIG4
45 JAM3
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with a wide range of afﬁnities either homotypically, heterotypically
(with other Ig receptors), or with other non-Ig-related proteins [16].
Members of this family have previously been used to explore other
extracellular protein interaction platforms. Jiang and Barclay
screened a panel of 36 Ig receptors for interactions against them-
selves using a 6  6 SPR array [17].Wright and coworkers developed
an enzyme-linked immunosorbent assay (ELISA)-style assay called
AVEXIS (avidity-based extracellular interaction screen) and used it
to screen more than 100 zebraﬁsh Ig receptors and leucine-rich re-
peat proteins against a library of 249extracellular proteins, identify-
ing a number of novel interactions [18,19].
Here we used a highly diverse secreted protein library in con-
junction with a set of 89 Ig receptor baits to develop protein micro-
arrays as an effective tool for large-scale extracellular interaction
screening. Our methodology, using a fast and robust multivalent
bait approach along with statistical hit calling and nonspeciﬁc
binding accounting, revealed top hits as known binding partners
and several new interactions for functional validation. These
results establish protein microarrays as an important technology
for characterization of the extracellular protein interactome.
Materials and methods
Cloning, protein expression, and puriﬁcation of bait Ig receptors
Residues encoding the extracellular domain of Ig receptors were
ampliﬁed by polymerase chain reaction (PCR) using Origene clones
or a complementary DNA (cDNA) library as templates. ClaI and AscI
restriction sites were incorporated at the 50 and 30 ﬂanking ends to
allow ligation into a C-terminal human Fc-tag pRK vector. Proteins
were transiently expressed in Chinese hamster ovary (CHO) cells at
a 1-L scale and puriﬁed, as described previously [20], over a protein
A column, followed by a Mono-Q and/or S200 sizing column to
remove degraded or aggregated protein if necessary. Proteins were
concentrated using Amicon concentrators (Millipore). For our
study, 89 Ig receptor Fc fusions were selected based on expression
levels in CHO cells and protein quality after puriﬁcation (Table 1).
Representative sodium dodecyl sulfate–polyacrylamide gel elec-
trophoresis (SDS–PAGE) gels of several bait proteins are shown in
Supplementary Figs. 1F–H (see Supplementary material).
Bait labeling and protein A microbead–Fc fusion complexes
All Fc fusion bait proteins were labeled with Amersham Cy5
monoreactive dye (GE Healthcare, cat. no. PA25001) and separated
from the free dye using desalting columns (Princeton Separation,
cat. no. CS-800). Dye to protein ratios, determined by ultraviolet
(UV) absorbance at OD280 and 650 nm, between 2.0 and 4.0 were
used. Cy5 conjugates were spun at 100,000g for 15 min in a table-
top ultracentrifuge (Beckman Coulter) at 4 C before use.
To form protein A microbead–Fc fusion complexes, 200-ll ali-
quots of 20 lg/ml Cy5-labeled Ig receptor protein in phosphate-
buffered saline (PBS) were individually mixed for 30 min at room
temperature with different volumes (0, 10, 20, 40, and 60 ll) of
stock protein A microbeads (Miltenyi Biotec, cat. no. 130-071-
001) on a tube rotator. The remaining uncomplexed Fc-tagged pro-
tein was then measured directly from the microbead solution via
an Octet biolayer interferometer (ForteBio). The sample containing
the minimal saturating volume of beads was selected based on this
analysis.
The microbead–Fc fusion complexes were then pelleted in a
tabletop centrifuge at 21,000g for 10 min and resuspended in
PBS/5% milk. To block binding to Fc-tagged proteins on the micro-
array, samples were supplemented with 1 mg/ml soluble protein A
immediately prior to the binding assay.Secreted protein microarray production
We compiled 1851 protein samples from the Genentech
secreted protein library (SPDI) [5]. The samples represent mostly
human proteins (>99%) and were expressed from either CHO, bac-
ulovirus, or Escherichia coli systems. The majority were poly-His
(948 proteins), poly-His/Gln (246 proteins), or C-terminally Fc
tagged (613 proteins). The remaining proteins were untagged. Prey
proteins were puriﬁed by standard afﬁnity puriﬁcation methods.
Representative SDS–PAGE gels of several prey proteins are shown
in Supplementary Fig. 1A–E. Protein concentrations were adjusted
to between 200 and 400 lg/ml when possible. Protein stocks were
diluted 1:1 with PBS/80% glycerol for long-term storage at 20 C
in 96-well plates. Working plates (384 wells) containing 10 ll of
samples in each well were generated from the stock plates.
Proteins were spotted with quill-type spotting pins (Arrayit, cat.
no. 946MP3) onto epoxysilane slides (SCHOTT, Nexterion slide E,
cat. no. 1064016) using a NanoPrint LM60 48-pin microarrayer
(Arrayit) at 60% relative humidity. To visualize the array for mask
ﬁtting and to aid in identifying sample carryover, bovine serum
albumin (BSA)-Cy3 (5 lg/ml in PBS/40% glycerol) was spotted in
duplicate between each protein sample. Next, 1 h after printing,
microarray slides were removed from the humidiﬁed environment
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skim milk powder, cat. no. LP0031) at 4 C. Slides were stored at
20 C in PBS/40% glycerol to prevent freezing.
The relative immobilization level for each Fc-, His/Gln-, and
His-tagged protein was determined by probing two replicate slides
with a Cy5-labeled anti-Fc antibody (Jackson ImmunoResearch,
cat. no. 109-176-170), a Cy5-labeled anti-His/Gln antibody (Genen-
tech), or a multivalent anti-His microbead (Miltenyi Biotec, cat. no.
130-091-124) detected with Cy5-labeled goat anti-mouse F(ab0)2
(Jackson ImmunoResearch, cat. no. 115-176-072). Data for anti-Fc
andanti-polyHis/Glnwerenormalized relative to anti-polyHis using
the mean background subtracted ﬂuorescence (F635 – B635)
value for each tag subset. Protein with background subtracted
ﬂuorescence values below 200, including 296 polyHis-, 135 poly-
His/Gln-, and 86 Fc-tagged proteins, were considered to have mini-
mal immobilization and are not counted in the total number of
unique proteins represented on the microarray. The remaining
1334 protein samples and their relative immobilization levels are
summarized in Supplementary Table 1, and the amino acid se-
quences for nonpurchased samples are provided in Supplementary
Table 2 (see Supplementary material). In a small fraction of cases,
spots showed anomalous anti-tag signal (deﬁned here as having
>20% signal from another tag). Based on our BSA-Cy3 printing con-
trols, the majority of these instances (15 of 24) could be attributed
to protein carryover (Supplementary Table 1). For the entire Ig
receptor set, we identiﬁed 9 false-positive hits due to carryover.
Although relatively minimal, these observations suggest that
carryover should still be controlled for.
Protein microarray processing
Slides were allowed to warm to room temperature in PBS/40%
glycerol and rinsed with PBST (PBS + 0.1% Tween 20) before load-
ing onto an automated a-Hyb hybridization station (Miltenyi Bio-
tech) for binding. The a-Hyb staining protocol was run at 15 C
as follows: wash with PBST for 1 min (step 1), load 200 ll of
1.0 mg/ml protein A (Sigma, cat. no. P7837) in 5% milk/PBST and
incubate for 30 min to prevent uncomplexed protein A microbeads
from binding Fc tags on the microarray (step 2), wash 5 times with
PBST for 1 min (step 3), load 200 ll of bait microbead complex in
5% milk/PBST in the presence of 1.0 mg/ml protein A and incubate
for 30 min (step 4), wash 5 times with PBST for 1 min (step 5), and
wash with PBS for 1 min (step 6). The slides were then immedi-
ately placed in individual 50-ml Falcon tubes and dried by spinning
at 900g for 5 min in a tabletop centrifuge. Slides were scanned with
a GenePix 4000B scanner (Molecular Devices). The Cy3 (532 nm)
and Cy5 (635 nm) emissions for each slide were measured using
a photomultiplier tube (PMT) setting that avoided signal satura-
tion. GenePix Pro 6.0 software (Molecular Devices) was used for
analysis. Representative images are shown in Supplementary
Fig. 2.
Data analysis
The scanned and intensity integrated data were saved as GPR
ﬁles in GenePix Pro 6.0 (Molecular Devices) and processed in R
using the limma package [21]. Preprocessing steps included back-
ground correction and within-chip normalization. For background
correction, a local background estimate based on the normal expo-
nential convolution model [22] was used. The ‘‘normexp’’ method
models the observed pixel intensities as a mixture of two random
variables, one normally distributed and the other exponentially dis-
tributed, representing background noise and signal, respectively.
After background correction, the log2 transformation of the back-
ground corrected signal was applied to correct the skew. The data
were then normalized by subtracting the mean and dividing bythe standard deviation. Further quantile normalization was applied
between the two replicate microarrays to put them on the same
scale. The normalized log2 signals were then used to score hits as
a function of the two replicate spots on each microarray according
to the following equation:score ¼
spot1þspot2
2  dﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃjspot1  spot2j þ 2
p : ð1Þ
The parameter d designates a lower signal threshold empirically
set at the 25th percentile of the total array ﬂuorescence. In the
denominator, the addition of 2 to the signal difference inﬂates the
variance measure for low signal spots and helps to normalize the
overall distribution of scores. Although other values for this factor
could be used, empirically the number 2 worked well. With scores
calculated for each slide, the results were then analyzed for the
intersection of high-scoring candidates between slides. To control
for slide variability, duplicate microarrays from separate spotting
runswere analyzed. An upper tail probability from the approximate
normal distribution of 0.0001 was used as the hit cutoff. Initial hits
were assigned to each microarray replicate separately, and the
intersection of these hits from both replicates was used to call ﬁnal
hits. Finally, an additional level of ﬁltering was needed to identify
and exclude proteins on the microarray that might bind nonspecif-
ically. To address this issue, ﬁnal hits for the complete Ig receptor
set were compiled (Supplementary Table 1). From this list, the
cumulative prey hit rate was determined and a data-driven
elimination threshold of 10% was used to remove nonspeciﬁc
binders.SPR validation
Hits were validated by SPR using a Biacore 3000 instrument
(Supplementary Figs. 3–8). Proteins were immobilized (or cap-
tured with immobilized anti-Fc antibody) on a CM5 chip at more
than 1000 resonance units (RU). Analytes were generally run at
50 lg/ml protein concentration in HBS-P buffer (0.01 M Hepes
[pH 7.4], 0.15 M NaCl, and 0.005% surfactant P20). Interaction pairs
were tested twice, once with each partner immobilized. In each
case, negative control proteins were immobilized on separate ﬂow
cells as speciﬁcity controls. Furthermore, negative control analytes
were run for each immobilized protein. An interaction was consid-
ered as validated if binding was detected in both orientations and
was not observed for negative controls.Results
Generating a functional secreted protein microarray
The SPDI library [5] is composed of more than 700 secreted or
extracellular domains from single transmembrane proteins indi-
vidually puriﬁed using Fc, polyHis, or polyHis/Gln tags. SPDI pro-
teins were spotted at 60% relative humidity from 40% glycerol in
PBS buffer to allow proteins to remain hydrated during the print
run. Importantly, glycerol also allows the printing plates to be
stored at 20 C and transferred to room temperature without
freeze–thawing that would risk protein inactivation. Keeping slides
hydrated at all times was critical to maintaining protein functional
activity (data not shown). The relative levels of proteins immobi-
lized on the microarray were determined by probing slides with
either anti-Fc, anti-polyHis, or anti-polyHis/Gln antibodies, con-
ﬁrming immobilization for 1334 protein samples representing
686 genes (Fig. 1A and Supplementary Table 1).
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interaction signal detection on protein microarrays
Although soluble ligands generally bind to cell surface receptors
with high afﬁnity, coreceptor interactions between two cell surface
proteins can bind with much lower afﬁnity and, therefore, must be
a technical consideration [17,18]. Voulgaraki and coworkers [23]
demonstrated microarray detection of a low-afﬁnity (KD  1 lM)
coreceptor interaction between CD200 and CD200R1 by generating
a multivalent analyte. We have developed an extension of this
approach, using Fc fusion constructs, that allows for the fast and
efﬁcient formation of multivalent bait particles. Protein A-coated
microbeads are used to capture Cy5-labeled Fc fusion protein from
solution (Fig. 1B). The optimal microbead to protein ratio isB
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Using the microbead complex method described above, we
selected an additional ﬁve Ig receptors with known ligands on the
microarray to evaluate speciﬁc versus nonspeciﬁc binding. The Ig
receptors selected have varying afﬁnities to their cognate ligands,
ranging from nanomolar (TIGIT and CD160) [2,7] to micromolar
(CD2 and CD200) [23,24], whereas JAM3 binds homotypically with
low afﬁnity and JAM2 with much higher afﬁnity [25]. Baits were
screened in duplicate, and the average ﬂuorescent signals for the
top hits for each screenwere determined (Fig. 2). In each case except
for CD2, the top hitswere the expected ligands and little nonspeciﬁc
binding was observed. JAM3 showed strong binding signal to the
JAM2 protein lots on the microarray and much weaker, but detecti-
ble, signals to several JAM3 samples. In addition to binding the two
protein lots of CD58 on the microarray, CD2 displayed unexpected
binding to TFF1, FGFR1, and SIGLEC9. Incidentally, these three pro-
teins were also present as top hits in several of the other screens,
but with much lower ﬂuorescent signal, suggesting that binding to
these proteins may represent general nonspeciﬁc interactions.
Screen of an extended Ig receptor set and identiﬁcation of speciﬁc
protein–protein interaction hits
To further validate the secreted protein microarray and investi-
gate the rate of nonspeciﬁc binding, we selected an additional 82 Ig
receptors, composed of both orphan receptors and receptors with
known binding partners present on the microarray, to screen (Ta-
ble 1). To eliminate user bias and develop a more standardized
method for hit determination, we developed a statistical scoring
scheme (see Materials and Methods). An upper tail probability
from a normal distribution ﬁt of the data was used as the hit cutoff
(Fig. 3A). The results were then analyzed for the intersection of hits
between two replicate slides (Fig. 3B). The intersection method
represents a more stringent methodology relative to taking a sim-
ple average where deviations on a single array can skew the re-
sults. To identify promiscuous binders on the microarray, we
hypothesized that these proteins could be identiﬁed and excluded
from consideration by determining the hit rate across the 89 inde-
pendent screens (Fig. 3C). A data-driven elimination threshold of a
10% prey hit rate was used and identiﬁed ﬁve protein samples
having highly nonspeciﬁc characteristics (Fig. 3D). Interestingly,
two of the ﬁve proteins (SIGLEC6 and SIGLEC9) are known sialic
acid binding proteins [26].
Evaluating true-positive and false-positive hit rates
We reexamined the data for CD200 and the screens represented
in Fig. 2 with our statistical scoring criteria. The results showed dis-
tinctly called hits versus the lower scoring false positives that were
identiﬁed on a single replicate only (Fig. 4). Using thismethodology,
we proceeded to analyze the entire dataset of 89 bait receptors and
identiﬁed 151 hits (Supplementary Table 1). Scores from multiple
hits deriving from different lots of the same protein were averaged
together, resulting in a total of 105 bait/prey interactions. The hits
sorted according to their mean score are plotted in Fig. 5. Table 2
summarizes known or expected hits and novel interactions vali-
dated by SPR. The majority of high-scoring interactions identiﬁed
represent true binding partners. For example, of the 53 top-half
scoring hits in Fig. 5, forty-ﬁve (85%) were known or expected. Of
the 8 unexpected hits in this group, 4 were validated positively
by SPR. Of the 52 lower scoring interactions, only 18 (35%) were
known or expected, and only 7 of the 34 unexpected hits were val-
idated positively by SPR. A total of 38 baits had no hits, and these
were generally orphans or did not have binding partners included
on the microarray. Moreover, 16 homotypic interactions weredetected, with 3 more (IGSF4B, JAM1, and HEPACAM2) identiﬁed
at a lower probability threshold. Of these 19 interactions, 2 have
not been reported in the literature (HEPACAM2 and LAIR1). The
only expected homotypic interactions not observed were for PVRL4
and PVRL3. The fact that wewere able to identify known homotypic
interactions in this set without signiﬁcant false positives suggests
that the microbead protein microarray approach represents a ro-
bust method for identifying this class of interaction. Themicroarray
scoring system we have developed appears to be sufﬁcient as a
general qualitative conﬁdence measure.Evaluating the inﬂuence of immobilization levels on false negatives
We investigated whether we could derive any general conclu-
sions on the inﬂuence of immobilization level on the false-negative
rate. Although our study was not designed to answer the limit of
sensitivity relative to immobilization levels, we can analyze the
data in aggregate by considering only hits that had more than a
single lot on the microarray. This compiled subset is summarized
in Supplementary Table 3. Analysis of false negatives and true pos-
itives for Fc-tagged proteins within this set shows that there is lit-
tle difference in the distribution of immobilization levels
(Supplementary Fig. 9A). The same is true for the His-tagged pro-
teins (Supplementary Fig. 9B). Moreover, the relative immobiliza-
tion levels do not show an obvious correlation with the mean hit
score derived from our statistical analysis, suggesting that above
a certain immobilization level there may be other signiﬁcant fac-
tors that contribute to the binding signal. Interestingly, the false-
negative to true-positive hit ratio for Fc- or His-tagged proteins
(Supplementary Fig. 9D) suggests that Fc-tagged prey proteins
are more effective for identifying hits with the class of proteins
used in this study.Discussion
Our aim in this study was to test the performance of protein
microarrays in identifying extracellular protein interactions. We
used a set of Ig receptors, with known and unknown binding part-
ners, and an unbiased statistical hit identiﬁcation algorithm to
evaluate the ability of the platform to detect known and novel
interactions. With 89 receptors screened against 686 represented
genes, effectively a total of 61,054 potential interactions were
probed. Based on the hit selection criteria applied and our SPR val-
idation results, we obtained an overall 70% true-positive to false-
positive hit ratio. The interactions identiﬁed largely represent the
expected interactions for this receptor set. Of the positive interac-
tions identiﬁed, 11 were novel. These results demonstrate that pro-
tein microarrays are an effective and robust technology for rapid
extracellular protein interaction screening.
The IgLON (NTM, NEGR1, and LSAMP), PVR, and CEACAM Ig
receptor subfamilies have members that are known to interact
within their own Ig subgroups [7,27,28]. We were able to recapit-
ulate the majority of these interactions. For example, all three
IgLON family members screened interacted with each other as well
as homotypically, and the six members of the PVR family screened
generally interacted with the expected speciﬁcity [7]. Of the novel
interactions identiﬁed, one of the highest scoring was between the
T cell costimulatory molecule CD80 and nerve growth factor recep-
tor NGFR. CARTPT, a hypothalamus-expressed secreted protein,
was found to interact with two CEACAM family members. MPZL3
bound to MPZL2, both of which are broadly expressed and belong
to the MPZ subfamily (this interaction was also recently identiﬁed
in a screen by Bushell and coworkers [18]). PSG5 bound TIE1, an
endothelial cell receptor regulating vascular development. The
trefoil protein TFF1 bound to ﬁve different orphan Ig receptors
Fig.3. Statistical methodology for hit determination. (A) Histograms of scores for two array replicates with the ﬁtted normal distribution and the 0.0001 probability cutoff
(vertical red line) indicated. Data for the CD200 screen is shown here as a representative example. Hits are represented by asterisks plotted above the x axis. (B)
Representative intersection plot for hit identiﬁcation. The histograms for arrays 1 and 2 shown in panel A can be considered as one-dimensional projections along the x and y
axes of the intersection plot, respectively. The dashed diagonal line represents equality. The horizontal and vertical lines are the individual 0.0001 probability cutoffs. There
are no array 1-only hits. Blue circles are array 2-only hits. Purple triangles represent hits against nonspeciﬁc binders. Black circles are intersection hits. (C) Histogram showing
the distribution of prey hit rates compiled from the screen of 89 Ig receptors. The majority of prey proteins have a hit rate of less than 5%. (D) Bar plot showing the top
promiscuous binders. Five proteins were found to be highly nonspeciﬁc, appearing in more than 10% of screens.
Secreted protein microarray platform / S.R. Ramani et al. / Anal. Biochem. 420 (2012) 127–138 133
Fig.4. Intersection plots for representative screens. Black circles (labeled) represent intersection hits scored as described in Materials and Methods. Red and blue circles
represent hits called on only a single array. The lower left square of each plot represents the 0.0001 percentile cutoff and contains all non-hit proteins. Results from screens of
CD200-Fc (A), CD200R1-Fc (B), TIGIT-Fc (C), JAM3-Fc (D), CD160-Fc (E), and CD2-Fc (F) baits are shown.
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Fig.5. Hit summary for the complete Ig receptor screen. A bar plot ranking of 105 interactions identiﬁed from the screen of 89 Ig receptors is shown. The interactions are
labeled in the bait/prey orientation (e.g., BTLA/TNFRSF14, where BTLA is the bait and TNFRSF14 was the hit). Blue bars represent known or expected interactions. Green bars
represent unexpected interactions that were validated by SPR. Interactions represented by gray bars were negative by SPR. Black circles along the lower axis indicate
homotypic interactions. If multiple lots of the same protein in the SPDI library were hit, their scores were averaged.
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TFF1 and TFF2. Trefoil proteins are expressed in the gastrointesti-
nal mucosa and are suggested to play a role in the maintenance
of epithelial integrity. These proteins may be involved in carbohy-
drate recognition, which might explain the broad binding speciﬁc-
ity [29]. Further studies will be needed to address the physiological
relevance of each of these interactions.
The ability to form multivalent bait particles to enhance signal
strength, especially for low-afﬁnity interactions, was an important
aspect of our ability to identify these interactions. It is less clear
whether multivalency of the immobilized prey is important. Pre-
sumably at high enough immobilization levels, proteins may be in
close enough proximity to act in a multivalent manner. Interest-
ingly, however, relative immobilization levels did not show a corre-
lation with mean hit score, suggesting that above a certain
threshold the amount of protein immobilized does not dominantly
contribute to the score. Moreover, in a few cases we found that
interactions appeared to be tag dependent. For example, ASAM
hit with an Fc-tagged ASAM lot but not with three other His-tagged
ASAM samples. Similarly, LSAMP, NEGR1, and NTM all hit against
NTM-Fc but notwith four other lots of NTM-His despite having sim-
ilar relative immobilization levels. Correspondingly, the false-nega-
tive to true-positive hit ratio for prey proteins with more than one
lot on the microarray was higher for His-tagged preys when com-
pared with Fc-tagged proteins. It is possible that the dimeric Fc
tag confers additional avidity, which allows these interactions to
be identiﬁed as hits. A more systematic study is needed to fully
evaluate the importance of prey multimerization on microarrays;
however, our current data suggest that C-terminally tagged Fc fu-
sions (or other multimerizing tag) for extracellular domains of sin-
gle-transmembrane receptors may be beneﬁcial for microarray
screens involving potentially low-afﬁnity coreceptor interactions.We also found that in certain instances not all lots of a protein
scored sufﬁciently high, even with the same tag, to be identiﬁed
as a hit under our methodology. There are several potential, and
possibly confounding, reasons for this. For instance, protein activity
or quality for a particular puriﬁcation lot may be compromised.
Similarly, there are several contributing factors thatmight result
in nonspeciﬁc binding. For example, proteins may be naturally
highly charged or hydrophobic. Some proteins may interact with
general carbohydrate motifs. There may be issues of protein quality
(e.g., some level of protein degradation, denaturation, or aggrega-
tion). Therefore, it is likely that in any large set of proteins, some
nonspeciﬁc binders will be present. The approach we describe here
accounts for nonspeciﬁc interactors by tracking their hit behavior
over many unrelated screens. As with any threshold method, an
appropriate cutoffmust be applied. Fortunately, wewere able to ac-
count for themajority of thenonspeciﬁcbinding events bydiscount-
ing hits from ﬁve protein samples on the array (TFF1-Fc, FGFR1-Fc,
SIGLEC9-Fc, TNFRSF13B-Fc, and SIGLEC6-Fc). Interestingly, TFF1,
FGFR1, andTNFRSF13Beachhad twoor three protein lots in the SPDI
library, and in each case only one lot was highly nonspeciﬁc. This
observation suggests that there was a protein quality problem for
these particular lot preparations and that these proteins did not dis-
play general nonspeciﬁc binding characteristics. Interestingly, there
was not an obvious correlation between high immobilization levels
andnonspeciﬁc binding activity. For example, the anti-Fc-Cy5 signal
for nonspeciﬁc FGFR1-Fcwas 2948, somewhat higher than the other
two lots with signals of 1670 and 1808. However, 140 other Fc-
tagged proteins had higher immobilization signals ranging from
2950 to 16,540. Similarly, TFF1-Fc had an immobilization signal of
only 1912. In addition, SDS–PAGE gel analysis did not reveal any
obvious deﬁciencies in these nonspeciﬁc protein samples. Overall,
we were encouraged by the fact that signiﬁcant nonspeciﬁc binding
Table 2
Complete list of interactions identiﬁed from Ig receptor set.
Screen Mean Score Hit Name
ASAM 5.1 ASAM
CD80 14.0 NGFR
CD80 12.2 CD274
CD80 10.7 CD28
CD80 9.4 CTLA4
CD274 15.1 PDCD1
CD274 8.1 CD80
BTLA 19.0 TNFRSF14
BTN3A1 7.4 TFF1
BTNL8 7.3 TFF1
CD160 10.2 TNFRSF14
CD2 6.7 CD58
CD200 8.6 CD200R1
CD200R1 15.0 CD200
CD226 10.3 PVR
CD226 10.0 PVRL2
CD300LD 4.7 TFF1
CEACAM1 9.9 CEACAM6
CEACAM1 9.7 CEACAM1
CEACAM1 9.2 CARTPT
CEACAM1 9.1 CEACAM8
CEACAM1 8.4 CEACAM7
CEACAM1 4.6 CEACAM5
CEACAM6 16.0 CEACAM8
CEACAM6 15.6 CARTPT
CEACAM6 15.2 CEACAM1
CEACAM6 14.6 CEACAM6
CEACAM6 9.5 CEACAM7
CEACAM6 8.5 CEACAM5
CTLA4 7.3 CD86
CTLA4 6.6 CD80
CXADR 5.6 AMICA1
CXADR 5.2 CXADR
ESAM 6.5 ESAM
FCRL4 10.0 TFF1
FCRL4 5.0 TFF2
NTM 10.7 LSAMP
NTM 9.7 NEGR1
NTM 6.2 NTM
Screen Mean Score Hit Name 
IGSF11 6.3 IGSF11
JAM2 12.2 JAM3 
JAM2 7.5 JAM2 
JAM3 10.6 JAM2 
JAM3 6.5 JAM3 
LAIR1 13.5 collagen
LAIR1 8.2 LAIR1 
PVRL4 11.6 PVRL1 
PVRL4 8.1 PVRL2 
PVRL4 4.2 TIGIT
LSAMP 11.4 NTM 
LSAMP 8.1 LSAMP 
LSAMP 4.0 NEGR1 
MPZL3 5.2 MPZL2 
NEGR1 8.2 NTM 
NEGR1 6.7 NEGR1 
NEGR1 6.5 LSAMP 
PDCD1 8.2 CD274 
PSG5 4.2 TIE1 
PVRL1 9.2 PVRL4 
PVRL1 8.6 PVRL3 
PVRL1 7.2 PVRL1 
PVRL2 14.3 CD226 
PVRL2 13.8 PVRL3 
PVRL2 10.7 PVRL2 
PVRL3 18.1 PVRL1 
PVRL3 16.1 PVRL2 
PVRL3 7.9 TIGIT
SIGLEC8 4.9 TFF1
SLAMF1 7.7 SLAMF1 
SLAMF7 5.6 SLAMF7 
TIGIT 17.2 PVRL2 
TIGIT 15.5 PVRL3 
TIGIT 14.0 PVRL4 
TIGIT 10.4 PVR 
Green = novel & SPR validated interaction 
Blue = known or expected interaction  
Note. Green: novel and SPR validated interaction. Blue: known or expected interaction. (For interpretation of the references to color in this table note, the reader is referred to the web version of this article.)
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study.
Each of the ﬁve nonspeciﬁc binding proteins appeared as hits in
more than 10% of screens. In actuality, this 10% cutoff was fairly
lenient. A cutoff of 5% would have served to eliminate 10 additional
false positives. Both VSIG4-Fc and mPLG-His had a hit frequency of
6% and accounted for 10 false positives combined. However, this
threshold would have also eliminated some cross-interacting Ig
subfamily interactions. For example, PVRL2 (binding to CD226,
PVRL2, PVRL3, PVRL4, and TIGIT) and TFF-His (binding to BTN3A1,
BTNL8, CD300LD, FCRL4, and SIGLEC8) also had hit frequencies of
6%. As more screens are conducted against the secreted protein
microarray, true nonspeciﬁc interactors would be expected to
maintain their hit frequency scores, whereas the values for speciﬁc
interactions such as PVRL2-Fc and TFF1-His would be expected to
decrease.
Nonspeciﬁc binding may also derive from the bait proteins
themselves, but these are much easier to identify due to high back-
ground binding on the microarrays. In our Ig receptor set, only two
baits (CEACAM4 and SIGLEC5) showed signiﬁcant background lev-
els and needed to be eliminated from the analysis. Interestingly,
SIGLEC5 is a sialic acid binding protein, similar to the nonspeciﬁc
prey proteins SIGLEC6 and SIGLEC9, suggesting that high back-
ground binding may be due to general sialic acid recognition.
Although it has been suggested that protein interaction net-
works may contain a number of ‘‘noisy’’ or nonfunctional interac-
tions [30], the results presented here suggest that extracellular
protein interactions are quite speciﬁc. It is clear that even between
members of the Ig receptor family, where there is signiﬁcant struc-
ture and sequence homology, truly selective interactions have
evolved and can be identiﬁed outside the cellular context. Never-
theless, in vivo it is likely that temporal and spatial expression dif-
ferences serve to regulate the interactions of cross-reacting Ig
subfamily members such as IgLON, PVR, and CEACAM. In these
cases, identiﬁcation of positive interactors in vitro can provide a
starting place for functional and spatiotemporal expression studies
[19,31].
Our data demonstrate the power of proteinmicroarrays for iden-
tifying extracellular protein interactions. Although establishing a
large protein library may initially require signiﬁcant resources, the
small amount of protein required to generate microarrays is a great
advantage. Relatively small-scale puriﬁcations can produce enough
material to theoretically print thousands of microarrays. For exam-
ple,withour current protocol, 10 lg of proteinwouldbe sufﬁcient to
print more than 5000 microarrays. We anticipate that, with the
development of more efﬁcient and high-throughput methods for
mammalian protein production and puriﬁcation, extracellular pro-
tein microarrays can readily be expanded to cover a larger fraction
of the secretome and will provide an especially powerful and rapid
platform for identifying extracellular protein interactions.Acknowledgments
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